CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Cox Troy Director | Grant or award · Stock Option (right to buy) | +29,804 | 29,804 | ||
| 2026-06-23 | Pavlov George Director | Grant or award | +3,932 | 28,932 | ||
| 2026-06-23 | Pavlov George Director | Grant or award · Stock Option (right to buy) | +14,902 | 14,902 | ||
| 2026-06-23 | Babler Martin Director | Grant or award | +7,864 | 7,864 | ||
| 2026-06-23 | Babler Martin Director | Grant or award · Stock Option (right to buy) | +29,804 | 29,804 | ||
| 2026-05-18 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −118,037 | $27.19 | $3.2M | 1,394,292 |
| 2026-05-18 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −198 | $28.15 | $6K | 1,394,094 |
| 2026-05-11 | Hanson Kristopher General Counsel | Sale 10b5-1 | −284 | $27.61 | $8K | 175,964 |
| 2026-05-11 | Hanson Kristopher General Counsel | Sale 10b5-1 | −846 | $28.70 | $24K | 175,118 |
| 2026-05-11 | Hanson Kristopher General Counsel | Sale 10b5-1 | −6,979 | $30.04 | $210K | 168,139 |
| 2026-05-11 | Hanson Kristopher General Counsel | Sale 10b5-1 | −5,808 | $30.56 | $177K | 162,331 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −342 | $27.57 | $9K | 1,525,967 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −877 | $28.70 | $25K | 1,525,090 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −6,871 | $30.04 | $206K | 1,518,219 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −5,890 | $30.56 | $180K | 1,512,329 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −29,624 | $27.48 | $814K | 1,531,096 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −1,582 | $28.56 | $45K | 1,529,514 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −3,205 | $29.20 | $94K | 1,526,309 |
| 2026-05-07 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −4,321 | $28.52 | $123K | 346,176 |
| 2026-05-07 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −117 | $29.10 | $3K | 346,059 |
Page 5 of 12 · 239 trades